FIELD: medicine, endocrinology, pharmacy. SUBSTANCE: invention relates to the medicinal preparation acting on the thyroid gland function, namely, to thyroid hormone L-thyroxine. Pharmaceutical composition comprises the following components, mas. p. p. per unit mass of L-thyroxine: L-thyroxine sodium salt, the therapeutically effective dose; lactose, 84.6-112.3; modified lactose, 767.9-974.5; stearate, 4.5-10.5. Ratio of lactose to modified lactose = (0.08-0.15) : 1. Pharmaceutical composition is made as tablet mainly. Prepared L-thyroxine-containing tablets comprise reduced amount of accessory substances as measure for 1 g of L-thyroxine, they satisfy to all requirements of the State Pharmacopoeia, XI edition and they fitness time is 2 years, not less. EFFECT: improved and valuable properties of composition. 7 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
PROLONGED ACTION PREPARATION OF DICLOFENAC SODIUM | 2002 |
|
RU2221559C1 |
ANTIHISTAMINE PHARMACEUTICAL COMPOSITION | 2003 |
|
RU2264814C2 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DIABETES MELLITUS (VARIANTS) | 2003 |
|
RU2241449C1 |
CARVEDILOL-BASE SOLID MEDICINAL FORM | 2001 |
|
RU2214243C2 |
PHARMACEUTICAL COMPOSITION POSSESSING SOPOROFIC EFFECT | 2004 |
|
RU2270010C2 |
ANTIFUNGAL PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2266745C2 |
ANTITUBERCULAR PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2248797C1 |
PHARMACEUTICAL ANTIULCEROUS COMPOSITION AND METHOD OF ITS PREPARING | 2001 |
|
RU2179022C1 |
METHOD FOR PRODUCING COMPOSITION AND COMPOSITION SHOWING ANTIBACTERIAL ACTIVITY | 2001 |
|
RU2182825C1 |
PHARMACEUTICAL COMPOSITION WITH CARDIOSELECTIVE BETA-ADRENERGIC ANTAGONIST (VARIANTS) | 2004 |
|
RU2256447C1 |
Authors
Dates
2003-05-27—Published
2002-03-29—Filed